-

EXAI Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Exscientia plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Exscientia plc (NASDAQ: EXAI) securities between March 23, 2022 and February 12, 2024. Exscientia in an artificial intelligence (“AI”) driven Pharma-tech company that engages in the design and develop differentiated medicines for diseases with high unmet patient needs.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating the Allegations that Exscientia plc's (EXAI) Former CEO's Conduct Violated the Company's Code of Business Conduct

According to the complaint, during the class period, defendants failed to disclose that: (i) defendant Hopkins (former Exscentia CEO and Director) had engaged in improper relationships with employees that were inconsistent with the Company’s standards and values; (ii) defendant Nicholson (former Exscentia COB) had prior knowledge of Hopkins’s relationships and had improperly addressed Hopkins’s misconduct without consulting the Board; (iii) the Company’s maintenance and enforcement of its Code of Business Conduct and Ethics was inadequate to safeguard against the foregoing conduct; and (iv) the foregoing failures subjected the Company to a heightened risk of disruptive leadership transitions and/or reputational harm.

When Exscientia revealed the truth on February 13, 2024, the Company's stock price fell $1.72 per share, or 22.9%, to close at $5.79 per share on February 13, 2024.

What Now: You may be eligible to participate in the class action against Exscientia plc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 25, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Exscientia plc settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:EXAI

Release Summary
Robbins LLP is Investigating the Allegations that Exscientia plc's (EXAI) Former CEO's Conduct Violated the Company's Code of Business Conduct
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the "Class Period"). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity.The complaint alleges that Fractyl Health misled investors regarding t...

Stockholder Alert: Robbins LLP Informs Investors of the GoDaddy Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired GoDaddy Inc. (NYSE: GDDY) common stock between September 3, 2025 and February 24, 2026 (the "Class Period"). GoDaddy is an internet domain registry, domain registrar, and web hosting company headquartered in Tempe, Arizona.The complaint alleges that GoDaddy failed to disclose to investors that it had initiate...

Stockholder Alert: Robbins LLP Informs Investors of the AEVEX Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired AEVEX Corp. (NYSE: AVEX) Class A common stock (a) between April 17, 2026 and June 4, 2026, and (b) pursuant to the Company's initial public offering ("IPO") on April 17, 2026 (the "Class Period"). AEVEX is a military technology contractor.The complaint alleges that AEVEX concealed a pre-arranged plan between...
Back to Newsroom